Role of B cells in pathogenesis of Collagen-induced Arthritis in Humanized Mice
B 细胞在人源化小鼠胶原诱导的关节炎发病机制中的作用
基本信息
- 批准号:8094660
- 负责人:
- 金额:$ 18.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptive TransferAffectAllelesAnimal ModelAntibodiesAntibody FormationAntigen PresentationAntigen-Presenting CellsAntigensApoptosisApoptoticArthritisAutoantibodiesAutoantigensAutoimmune DiseasesAutoimmune ResponsesAutoimmunityB cell differentiationB-Cell ActivationB-Lymphocyte EpitopesB-LymphocytesBiologicalCell CountCell SurvivalCell physiologyCellsCollagen ArthritisCollagen Type IICyclic PeptidesDataDefectDendritic CellsDevelopmentDiagnosisDiseaseEpitope MappingEpitopesFamilyFemaleFibrinogenFreund&aposs AdjuvantGenesGoalsHLA-DQ8 antigenHeat-Shock Proteins 70HumanHybridomasHyperactive behaviorImmune responseImmunizationIn VitroIncidenceIndividualKnock-outKnockout MiceLeadLigandsLightMS4A1 geneMapsMeasuresMediatingModelingMusPathogenesisPathologyPatientsPeptide antibodiesPeptidesPeripheralPhenotypePlasma CellsPreventiveProcessProductionProteinsReceptors, Antigen, B-CellRegulationResistanceRheumatoid ArthritisRheumatoid FactorRoleSerumSeveritiesSex BiasSymptomsSynovial FluidT cell responseT memory cellT-Cell ActivationT-LymphocyteT-Lymphocyte EpitopesTALL-1 proteinTLR4 geneTLR5 geneTNF geneTNFRSF10A geneTestingToll-like receptorsTransgenic MiceTransgenic OrganismsWomanWorkautoreactive B cellautoreactive T cellchemokinechemokine receptorcyclic citrullinated peptidecytokinedisabling diseasehuman leukocyte antigen genein vivomacrophagemenmicrobialpublic health relevancereceptorreceptor expressionresearch studyresistant strainresponserituximabsynthetic peptidetrafficking
项目摘要
DESCRIPTION (provided by applicant): Rheumatoid arthritis (RA) and its animal model collagen-induced arthritis (CIA) are known to be T and B cell dependent diseases. HLA-DQ8 and DRB1*0401 molecules render humans and mice susceptible to develop arthritis while DQ6 and DRB1*0402 provide protection. CIA susceptible HLA transgenic mice produce rheumatoid factor and anti-cyclic citrullinated peptide (CCP) antibodies similar to that in patients. Absence of CIA and low cellular responses in B cell knockout mice suggests that the autoreactive B cells, in addition to producing antibodies may also be involved in presenting auto antigens to T cells. Improvement in ACR response criteria after depletion of B cells in patients further underscores the role of B cells in arthritis. However, the exact role of B cells in antigen presentation and their regulation in susceptible versus resistant strains of transgenic mice remains unclear. B cell function is regulated by B cell receptor, BCR, as well as other B cell specific receptors like BAFF-R. Our hypothesis is that B cells in transgenic mice carrying RA susceptible HLA gene have a defect in regulation which occurs through B cell receptor leading to hyperactivity and increased survival of autoreactive B cells. Females have hyperactive B cells which contribute towards the development of autoantibodies and presentation of antigens to T cells leading to increased incidence in females. Our preliminary data is consistent with this notion. Recent studies have shown that B cell responses are controlled by TLRs. In this study we will address the mechanism by which B cells contribute towards pathogenesis of collagen-induced arthritis in transgenic mice using mice expressing both CIA-susceptible and resistant HLA genes. In aim1, we will define the requirement of B cells as antigen presenting cells in pathogenesis of CIA. In aim 2 we will test our hypothesis if hyperactivity of B cell responses and epitope spreading in genetically susceptible mice leads to pathogenic response. Also, since not all transgenic mice positive for RA susceptible allele develop arthritis, potential differences in B cell activation status in those that develop arthritis versus that do not will be determined. In aim 3, we will determine the control of B cell responses by Toll like receptors, especially, TLR4 in this model. These transgenic mice and experiments proposed here should provide a mechanism of pathogenesis in context of B cells and narrow the focus of B cell-directed therapy. PUBLIC HEALTH RELEVANCE: Rheumatoid arthritis is a disabling disease, affecting women more often than men. B cells produce rheumatoid factor and other autoantibodies. In this study we will use mice that express human arthritis associated genes to delineate the role of B cells in rheumatoid arthritis patients. These humanized mice mimic rheumatoid arthritis in pathology and sex-bias. Arthritic mice produce autoantibodies like rheumatoid factor and anti-cyclic citrullinated peptide antibodies that are used for diagnosis of rheumatoid arthritis. We will determine if B cells can present pathogenic antigen and if there is a defect in regulation of B cells in arthritis susceptible mice. The information gained using this unique model may be instructive in developing preventive immunointervention for ongoing arthritis especially in women.
描述(由申请人提供):类风湿关节炎(RA)及其动物模型胶原诱导关节炎(CIA)是已知的T和B细胞依赖性疾病。HLA-DQ8和DRB1*0401分子使人和小鼠易患关节炎,而DQ6和DRB1*0402分子提供保护。CIA易感HLA转基因小鼠产生与患者相似的类风湿因子和抗环瓜氨酸肽(CCP)抗体。在B细胞敲除小鼠中,CIA缺失和低细胞反应表明,自身反应性B细胞除了产生抗体外,还可能参与将自身抗原呈递给T细胞。患者B细胞耗竭后ACR反应标准的改善进一步强调了B细胞在关节炎中的作用。然而,B细胞在易感和耐药转基因小鼠中抗原呈递及其调控中的确切作用尚不清楚。B细胞的功能受B细胞受体BCR以及其他B细胞特异性受体如BAFF-R的调控。我们的假设是,携带RA易感HLA基因的转基因小鼠的B细胞通过B细胞受体发生调控缺陷,导致自身反应性B细胞过度活跃和存活增加。女性有过度活跃的B细胞,这有助于自身抗体的产生和抗原向T细胞的呈递,导致女性发病率增加。我们的初步数据与这个观点是一致的。最近的研究表明,B细胞的反应是由tlr控制的。在这项研究中,我们将利用表达cia敏感和HLA耐药基因的小鼠,探讨B细胞在转基因小鼠胶原诱导关节炎发病机制中的作用。在目的1中,我们将定义B细胞作为抗原呈递细胞在CIA发病过程中的需要。在目标2中,我们将验证我们的假设,即B细胞反应的过度活跃和基因易感小鼠的表位扩散是否会导致致病性反应。此外,由于并非所有RA易感等位基因阳性的转基因小鼠都会患上关节炎,因此将确定患关节炎的小鼠与未患关节炎的小鼠在B细胞激活状态上的潜在差异。在目的3中,我们将确定Toll样受体,特别是TLR4在该模型中对B细胞反应的控制。这些转基因小鼠和本文提出的实验将提供B细胞背景下的发病机制,并缩小B细胞定向治疗的焦点。公共卫生相关性:类风湿性关节炎是一种致残疾病,女性比男性更常受影响。B细胞产生类风湿因子和其他自身抗体。在这项研究中,我们将使用表达人类关节炎相关基因的小鼠来描述B细胞在类风湿关节炎患者中的作用。这些人源化小鼠在病理和性别偏见上模仿类风湿关节炎。关节炎小鼠产生自身抗体,如类风湿因子和抗环瓜氨酸肽抗体,用于类风湿关节炎的诊断。我们将确定B细胞是否能呈递致病性抗原,以及在关节炎易感小鼠中B细胞的调节是否存在缺陷。使用这种独特的模型所获得的信息可能对发展预防性免疫干预治疗正在进行的关节炎具有指导意义,特别是在女性中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Veena Taneja其他文献
Veena Taneja的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Veena Taneja', 18)}}的其他基金
Impact of smoking on immune response and arthritis in humanized mice
吸烟对人源化小鼠免疫反应和关节炎的影响
- 批准号:
7950248 - 财政年份:2010
- 资助金额:
$ 18.86万 - 项目类别:
Impact of smoking on immune response and arthritis in humanized mice
吸烟对人源化小鼠免疫反应和关节炎的影响
- 批准号:
8131699 - 财政年份:2010
- 资助金额:
$ 18.86万 - 项目类别:
Role of B cells in pathogenesis of Collagen-induced Arthritis in Humanized Mice
B 细胞在人源化小鼠胶原诱导的关节炎发病机制中的作用
- 批准号:
8293425 - 财政年份:2009
- 资助金额:
$ 18.86万 - 项目类别:
Role of B cells in pathogenesis of Collagen-induced Arthritis in Humanized Mice
B 细胞在人源化小鼠胶原诱导的关节炎发病机制中的作用
- 批准号:
7893091 - 财政年份:2009
- 资助金额:
$ 18.86万 - 项目类别:
Role of B cells in pathogenesis of Collagen-induced Arthritis in Humanized Mice
B 细胞在人源化小鼠胶原诱导的关节炎发病机制中的作用
- 批准号:
8080421 - 财政年份:2009
- 资助金额:
$ 18.86万 - 项目类别:
Role of B cells in pathogenesis of Collagen-induced Arthritis in Humanized Mice
B 细胞在人源化小鼠胶原诱导的关节炎发病机制中的作用
- 批准号:
7727199 - 财政年份:2009
- 资助金额:
$ 18.86万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 18.86万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 18.86万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 18.86万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 18.86万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 18.86万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 18.86万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 18.86万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 18.86万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 18.86万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 18.86万 - 项目类别: